Johns Hopkins researchers have designed a new vaccine that, in combination with low-dose chemotherapy, makes pancreatic cancer susceptible to immunotherapy for the first time. [Category: Pancreatic Cancer] http://www.medicalnewstoday.com/articles/278400.php
Read More
No comments:
Post a Comment